Thea Pharma Inc. Statement Related to Akorn’s Voluntary Nationwide Recall of Various Human and Animal Drug Branded Ophthalmic Products within Expiry Due to Company Shutdown

Thea Portfolio of Products Acquired from Akorn are not Affected by this Recall WALTHAM, Mass., April 28, 2023 /PRNewswire/ — Thea Pharma Inc. (“Thea”), the U.S. subsidiary of Europe’s leading independent pharmaceutical company, Laboratoires Théa, dedicated to the research, development,…